Devices allow Health Sciences and other college collaborators greater scale and cost-effective methods to improve care.
Category Archives: AZBio News
HonorHealth Research Institute joins City of Hope and TGen in creating method for scoring pancreatic cancer patients for surgery
SCOTTSDALE, Ariz. — A trio of premier Southwest biomedical research centers — HonorHealth Research Institute, City of Hope and the Translational Genomics Research Institute (TGen), part of City of Hope — have developed a more precise method that may help determine when it is best to surgically remove of pancreatic cancer tumors.Continue reading
CND Life Sciences Closes Series Seed 3 Round, Reaches $12.5 million in Total Equity Raised
CND raised an additional $1 million in venture financing from Top Corner Capital
University of Arizona College of Medicine – Phoenix Researchers Awarded ABRC Grants
ABRC Awards Prestigious Grants to Eight Researchers at the College. Awards will fund projects in a myriad of vital areas of translational researchContinue reading
TGen-led Study Tracks Infection and Immunity Across the Universe of Human Viruses Over Time
Results offer glimpse into the future of forecasting infection and immunityContinue reading
Dr. David Gullen to hand over Flinn Foundation board chair after more than two decades of service
Dr. Eric Reiman, nationally recognized Alzheimer’s researcher, selected as new chairContinue reading
HonorHealth Research Institute makes key contributions to cancer breakthrough for women
SCOTTSDALE, Ariz.– HonorHealth Research Institute played a key role in what is being described as a substantial improvement in the treatment of primary advanced or first recurrent endometrial cancer, the nation’s most common gynecological malignancy.Continue reading
Cutting Edge Medical Technology Company CND Life Sciences Announces Grand Opening of Global Headquarters and Laboratories in Scottsdale
Company Focuses on Innovative Diagnosis and Treatment of Neurodegenerative DiseasesContinue reading
C-Path Appoints Key Scientific Leaders to Executive Roles
TUCSON, Ariz., March 29, 2023 — Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the organization. Cheryl D. Coon, Ph.D., joins C-Path as the Vice President for the Clinical Outcome Assessment (COA) Program. Shu Chin Ma, Ph.D., M.Sc., M.Phil., EMBA, has been named Vice President of Model-Informed Drug Development (MIDD) and the Quantitative Medicine (QuantMed) Program. Alexandre Bétourné, Ph.D., Pharm.D., has been promoted to Executive Director of the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP).Continue reading
Wexford Science + Technology launches the SciTech Venture Fund focused on early stage startups
Wexford Science + Technology announced last week it has launched its own venture fund focused on investing in early and late-stage seed opportunities, as well as its first two investments through the fund. Named the SciTech Venture Fund, this new initiative for Wexford “aims to partner with university and regional funds to provide startups with the financial support, connections and resources they need to grow and thrive.” The fund will initially focus on life science and technology companies in one of the 17 markets where Wexford Science + Technology already operates, including Phoenix, according to a press release.Continue reading